On Tuesday, an Orange County jury found that Allergan Inc. was not liable in the death of a 7-year-old girl who was being treated with Botox for severe cerebral palsy. In actuality, the court never got to the question of whether or not Botox had caused the girl's death, as they found the warning labels to be satisfactory. 

However, the drugmaker is not out of the woods yet - Allergan faces yet another civil trial next month.

The California wrongful death case garnered a fair bit of attention, as it was the first time Botox has been implicated in the death of an individual being treated with the drug.

In addition to its mainstream use as a facial rejuvenator, Botox is occasionally used to relax muscles and help younger patients retain the ability to walk. In some cases, Botox can even prevent the need for surgery.

Kristen Spears, whose mother filed the wrongful death suit, had been receiving large amounts of Botox since the age of six in order to combat debilitating limb spasticity as a result of her cerebral palsy. She passed away in 2007 after suffering respiratory failure, which was prompted by a bout with pneumonia. 

Her mother believed that Kristin's case of pneumonia was caused by a Botox overdose. In the lawsuit, Dee Spears, accused Allergan of failing to clearly disclose the risks inherent in the drug.

Still, the jury ruled that the company was not to be held liable in Jessica's death.

It was a frustrating verdict for the plaintiffs, especially considering a U.S. Food and Drug Administration's ruling last month which demanded Allergen update Botox labels to more accurately disclose potentially serious side effects.

Related Resources: